| Product NDC: | 0904-5657 |
| Proprietary Name: | Clonidine Hydrochloride |
| Non Proprietary Name: | Clonidine Hydrochloride |
| Active Ingredient(s): | .2 mg/1 & nbsp; Clonidine Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0904-5657 |
| Labeler Name: | Major Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA070975 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20061120 |
| Package NDC: | 0904-5657-61 |
| Package Description: | 100 TABLET in 1 BOX, UNIT-DOSE (0904-5657-61) |
| NDC Code | 0904-5657-61 |
| Proprietary Name | Clonidine Hydrochloride |
| Package Description | 100 TABLET in 1 BOX, UNIT-DOSE (0904-5657-61) |
| Product NDC | 0904-5657 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Clonidine Hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20061120 |
| Marketing Category Name | ANDA |
| Labeler Name | Major Pharmaceuticals |
| Substance Name | CLONIDINE HYDROCHLORIDE |
| Strength Number | .2 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |